Feedback / Questions
A2B395 - A2 Biotherap
https://www.businesswire.com/news/home/20250624143809/en/A2-Bio-Announces-First-Patient-Dosed-in-DENALI-1-Phase-12-Clinical-Study-of-A2B395-a-Novel-Allogeneic-Precision-CAR-T-Cell-Therapy-for-Patients-with-Solid-Tumors-that-Express-EGFR
Jun 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next